Status:
UNKNOWN
Bone Denisty Change in Children With Beta Thalassemia Major
Lead Sponsor:
Marwa Hassan Abdelhamed Hassan
Collaborating Sponsors:
Assiut University
Conditions:
Evaluate Bone Denisty Changes in Children With Beta Thalassemia Major
Eligibility:
All Genders
10-18 years
Brief Summary
Bone denisty changes in children with beta thalassemia major
Detailed Description
Beta Thalassemia major (TM) is a hereditary disease caused by defective Beta globin chain synthesis, resulting in abnormal as well as a decreased quantity of globin chains, ineffective erythropoiesis,...
Eligibility Criteria
Inclusion
- \- Patient diagnosed as B thalassemia major of both sexes, age range from 10-18 year, who are poorly controlled on frequant blood transfusion. The patient who doesn't have Hb level from 9-10 g/dl, in almost always less than 9 g/dl.
Exclusion
- Known metabolic bone disease. Less than 10 year or more than 18 year. Bone disease Other than hemolytic anemia.
Key Trial Info
Start Date :
December 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06069089
Start Date
December 15 2023
End Date
December 31 2024
Last Update
October 5 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.